Katie Quinn
0009-0006-6905-2257
Guardant (United States)
1 paper found
Refreshing results…
Plasma versus tissue tumor mutational burden as biomarkers of durvalumab plus tremelimumab response in patients with metastatic colorectal cancer in the CO.26 trial
Missing publications? Search for publications with a matching author name.